Power analysis is important because it tells researchers how many participants they need to detect a real effect in their study. Without it, a study can easily end up too small to find meaningful results, wasting time, money, and the effort of everyone involved. It’s the difference between designing a study that can actually answer a question and one that was never equipped to in the first place.
What Power Analysis Actually Does
Statistical power is the probability of detecting an effect that genuinely exists. If a treatment works, power tells you how likely your study is to pick that up. A study with 80% power has a 20% chance of missing a real effect entirely, declaring “no difference” when there actually is one. That missed detection is called a Type II error, and it’s one of the most common and preventable problems in research.
Power analysis ties together four interconnected factors: sample size, effect size, significance level (alpha), and the power itself. Effect size is essentially how big the difference is between two groups, expressed relative to the variability in the data. Alpha is the threshold for how much risk of a false positive you’re willing to accept, typically set at 5%. Once you fix any three of these four factors, the fourth is determined. The most common use is to plug in your desired power level, your expected effect size, and your alpha, then calculate how many participants you need.
The Standard Threshold and Why It Exists
The widely accepted target for power is 0.80, or 80%. This means you’re accepting a 20% chance of missing a real effect. For higher-stakes research, such as large clinical trials, researchers often aim for 90% power instead. These thresholds are conventions rather than scientifically derived cutoffs, but they represent a practical balance. Pushing power higher requires substantially more participants, which costs more and takes longer. Letting it drop below 80% makes the study unreliable enough that the results become difficult to trust either way.
That said, a study with power below 0.80 isn’t automatically worthless. It simply means the risk of a false negative is higher than the research community generally considers acceptable.
Preventing Wasted Studies
An underpowered study is one that enrolled too few participants to have a realistic chance of detecting the effect it set out to find. The result is often a non-significant finding that doesn’t tell you whether the treatment failed or the study was simply too small. This ambiguity is a major source of waste in science. An estimated $28 billion is lost annually on irreproducible preclinical research in the United States alone, and low statistical power is one of the key contributing factors.
The reproducibility problem is well documented. A 2016 survey of over 1,500 scientists published in Nature found that 90% believed there is a reproducibility crisis. When major replication projects have attempted to reproduce published findings across fields like psychology, economics, cancer biology, and social sciences, success rates have ranged from roughly 43% to 67%. Original studies consistently reported larger effect sizes than the replications found, a pattern consistent with underpowered studies that can only produce significant results when random chance inflates the apparent effect.
The Ethical Case for Power Analysis
In clinical research, underpowered studies raise serious ethical concerns. Every trial exposes participants to some degree of risk or inconvenience, whether from experimental treatments, invasive measurements, or simply the time and effort of participation. If a study is too small to produce valid results, those participants accepted risk for nothing. Ethics review boards in the United States are expected to assess scientific validity before approving a study, and a trial that cannot reasonably detect a meaningful treatment effect lacks that validity.
Underpowered trials also divert participants, staff, and funding away from properly designed studies that could generate useful knowledge. This makes power analysis not just a statistical formality but a basic obligation to the people who volunteer for research.
How Researchers Choose the Right Effect Size
The trickiest part of power analysis is deciding what effect size to plan for. One approach uses standardized benchmarks: small, medium, and large effects defined by statistical convention. But the more practical approach, especially in clinical research, is to base the calculation on the minimum clinically important difference. This is the smallest improvement that would actually change how a doctor treats a patient or how a patient experiences their condition.
For example, one surgeon might consider a 5% improvement in outcomes meaningful enough to switch treatments, while another might require a 10% improvement. Ideally, a panel of experts, stakeholders, and patients decides what counts as clinically meaningful, and the study is powered to detect that specific threshold. The goal isn’t to enroll as many people as possible to reach statistical significance. It’s to recruit enough people to detect the effect that would matter in practice, and no more.
Avoiding Both Overspending and Underspending
Power analysis protects against recruiting too few participants, but it also prevents recruiting too many. Every additional participant in a study costs money for recruitment, testing, follow-up, and data management. In large-scale trials, these costs add up quickly. If 200 participants would give you 80% power to detect your target effect, enrolling 500 doesn’t make the study twice as good. It makes it unnecessarily expensive. Power analysis finds the minimum sample size consistent with your scientific goals, which is especially important when budgets are tight or when the research involves animals, where ethical guidelines specifically call for using the fewest subjects possible.
The National Institutes of Health expects grant applicants to include power calculations in their proposals. A typical justification might read something like: “A sample size of 10 mice per group will provide at least 80% power to detect the specified difference between treated and control groups with a 5% significance level.” Funding bodies use these calculations to evaluate whether a proposed study is designed to succeed.
When Power Analysis Should Happen
Power analysis is meant to be done before a study begins. This prospective approach lets researchers plan their recruitment, budget, and timeline around a sample size they know is adequate. It provides the critically important numbers needed to detect meaningful differences while keeping resource use efficient.
Post-hoc power analysis, done after a study has already collected its data, is a different story. Because it substitutes the observed effect size for the true population effect size, it’s subject to the same sampling variability that makes small studies unreliable in the first place. For medium effect sizes, post-hoc power estimates can vary wildly even with 100 participants per group. The scientific consensus is that post-hoc power calculations are generally uninformative. Power describes the probability of a future event. Calculating it after the event has already occurred doesn’t provide the information researchers think it does.
Tools for Running a Power Analysis
The most widely used tool is G*Power, a free program from Heinrich-Heine-Universität Düsseldorf that handles power calculations for a broad range of statistical tests. To run an analysis, you specify your null and alternative hypotheses, choose the statistical test you plan to use, enter your expected effect size and desired alpha level, set your target power, and the software returns the required sample size. It also works in reverse: if your sample size is fixed, it can tell you what power you’ll have to detect a given effect.
The process forces researchers to think carefully about their study before collecting any data. What exactly are they testing? How big an effect would be meaningful? What kind of statistical test fits their design? These are questions that improve study quality whether or not someone ever opens the software.